Showing 21 - 40 results of 61 for search '"Fowlpox"', query time: 0.08s Refine Results
  1. 21
  2. 22

    Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. by Webster, D, Dunachie, S, McConkey, S, Poulton, I, Moore, A, Walther, M, Laidlaw, S, Peto, T, Skinner, M, Gilbert, S, Hill, A

    Published 2006
    “…We report on two such vaccine constructs, modified vaccinia virus Ankara and FP9 (an attenuated fowlpox virus) both expressing the pre-erythrocytic malaria antigen thrombospondin-related adhesion protein and a string of CD8+ epitopes (ME-TRAP). …”
    Journal article
  3. 23

    Negligible effect of chicken cytokine IL-12 integration into recombinant fowlpox viruses expressing avian influenza virus neuraminidase N1 on host cellular immune responses by Nor Majid, Nadzreeq, Omar, Abdul Rahman, Abdul Razak, Mariatulqabtiah

    Published 2020
    “…This study describes the construction and cellular responses of recombinant fowlpox viruses (rFWPV) strain FP9, co-expressing NA N1 gene of AIV A/Chicken/Malaysia/5858/2004, and chicken IL-12 gene. …”
    Get full text
    Article
  4. 24

    Verification of H5 gene expression from H5-recombinant fowlpox viruses co-expressing host cytokine using indirect immunofluorescence antibody test (IFAT) by Steffi, Julan Wan

    Published 2015
    “…Fowlpox virus (FWPV) has been used in vaccine development against avian influenza virus (AIV) by the expression of the AIV haemagglutinin (HA) gene. …”
    Get full text
    Project Paper Report
  5. 25

    Verification of H5 and IL-15 gene expressions from H5-recombinant fowlpox viruses coexpressing host cytokine by using sds-page and western blotting by Zulkifli, Nurul Farhana

    Published 2015
    “…In this study, the recombinant fowlpox virus (rFWPV) were analysed by using SDS-PAGE and Western blotting to verify the expression of H5 and IL-15 genes. …”
    Get full text
    Project Paper Report
  6. 26

    NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus. by Chen, J, Dawoodji, A, Tarlton, A, Gnjatic, S, Tajar, A, Karydis, I, Browning, J, Pratap, S, Verfaille, C, Venhaus, R, Pan, L, Altman, D, Cebon, J, Old, L, Nathan, P, Ottensmeier, C, Middleton, M, Cerundolo, V

    Published 2015
    “…To address this question, we carried out a randomized clinical trial in 39 high-risk, resected melanoma patients vaccinated with NY-ESO-1 ISCOMATRIX, and then boosted with repeated injections of either recombinant fowlpox virus encoding full length NY-ESO-1 (rF-NY-ESO-1) (Arm A) or NY-ESO-1 ISCOMATRIX alone (Arm B). …”
    Journal article
  7. 27

    Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide. by Vázquez Blomquist, D, Green, P, Laidlaw, S, Skinner, M, Borrow, P, Duarte, C

    Published 2002
    “…Here, we report the expression of a multiepitope polypeptide (TAB9) composed of the central 15 amino acids of the V3 loop from six different isolates of HIV-1 in a fowlpox virus (FWPV) vector, and the use of this vector (FPTAB9LZ) to induce strong HIV-specific CD8+ T cell responses in mice. …”
    Journal article
  8. 28

    Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. by Anderson, R, Hannan, C, Gilbert, S, Laidlaw, S, Sheu, E, Korten, S, Sinden, R, Butcher, G, Skinner, M, Hill, A

    Published 2004
    “…In this study, we have investigated the use of attenuated fowlpox virus (FPV) strains as recombinant vaccine vectors for eliciting CD8(+) T cells against Plasmodium berghei. …”
    Journal article
  9. 29
  10. 30

    Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya by Bejon, P, Peshu, N, Gilbert, S, Lowe, B, Molyneux, C, Forsdyke, J, Lang, T, Hill, A, Marsh, K

    Published 2006
    “…These vaccines used the attenuated fowlpox strain FP9 and the MVA recombinant for either of 2 preerythrocytic malaria antigens, multiple preerythrocytic-stage epitopes joined with the preerythrocytic-stage antigen TRAP (ME-TRAP) and the circumsporozoite protein (CS). …”
    Journal article
  11. 31

    Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya. by Bejon, P, Peshu, N, Gilbert, S, Lowe, B, Molyneux, C, Forsdyke, J, Lang, T, Hill, A, Marsh, K

    Published 2006
    “…These vaccines used the attenuated fowlpox strain FP9 and the MVA recombinant for either of 2 preerythrocytic malaria antigens, multiple preerythrocytic-stage epitopes joined with the preerythrocytic-stage antigen TRAP (ME-TRAP) and the circumsporozoite protein (CS). …”
    Journal article
  12. 32

    Evidence of a Possible Viral Host Switch Event in an Avipoxvirus Isolated from an Endangered Northern Royal Albatross (<i>Diomedea sanfordi</i>) by Subir Sarker, Timothy R. Bowden, David B. Boyle

    Published 2022-02-01
    “…Here we report evidence for a possible host switching event with a fowlpox-like virus recovered from an endangered northern royal albatross (<i>Diomodea sanfordi</i>)—a species of <i>Procellariiformes</i>, unrelated to <i>Galliformes</i>, not previously known to have been infected with fowlpox-like viruses. …”
    Get full text
    Article
  13. 33

    Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses. by Taracha, E, Bishop, R, Musoke, A, Hill, A, Gilbert, S

    Published 2003
    “…T-cell responses induced by priming with either plasmid DNA or fowlpox virus 85A constructs were enhanced by boosting with modified vaccinia virus Ankara expressing the same antigen administered intradermally. …”
    Journal article
  14. 34

    Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy by Hu Shunlin, Yao Chunfeng, Cao Yongzhong, Xu Lijun, Liu Wujie, Gu Min, Liu Xiufan

    Published 2011-03-01
    “…Two groups of SPF chickens, 18 each, were vaccinated with the two recombinant fowlpox viruses and challenged by Go/JS6/05 at 3 weeks post-immunization. …”
    Get full text
    Article
  15. 35

    Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum cir... by Walther, M, Thompson, F, Dunachie, S, Keating, S, Todryk, S, Berthoud, T, Andrews, L, Andersen, R, Moore, A, Gilbert, S, Poulton, I, Dubovsky, F, Tierney, E, Correa, S, Huntcooke, A, Butcher, G, Williams, J, Sinden, R, Hill, A

    Published 2006
    “…Here we report a series of trials assessing recombinant fowlpox virus and modified vaccinia virus Ankara encoding the Plasmodium falciparum circumsporozoite protein in various prime-boost combinations, doses, and application routes. …”
    Journal article
  16. 36

    Avipoxviruses: infection biology and their use as vaccine vectors by Tryland Morten, Weli Simon C

    Published 2011-02-01
    “…APVs are transmitted by aerosols and biting insects, particularly mosquitoes and arthropods and are usually named after the bird species from which they were originally isolated. The virus species Fowlpox virus (FWPV) causes disease in poultry and associated mortality is usually low, but in flocks under stress (other diseases, high production) mortality can reach up to 50%. …”
    Get full text
    Article
  17. 37

    Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. by Webster, D, Dunachie, S, Vuola, J, Berthoud, T, Keating, S, Laidlaw, S, McConkey, S, Poulton, I, Andrews, L, Andersen, R, Bejon, P, Butcher, G, Sinden, R, Skinner, M, Gilbert, S, Hill, A

    Published 2005
    “…Here, we report that substitution of plasmid DNA as the priming vector with a specific attenuated recombinant fowlpox virus, FP9, vaccine in such prime-boost regimes can elicit complete sterile protection that can last for 20 months. …”
    Journal article
  18. 38

    Progress in DNA-based heterologous prime-boost immunization strategies for malaria. by Moore, A, Hill, A

    Published 2004
    “…We have evaluated this heterologous prime-boost approach using the Plasmodium berghei mouse model for immunogenicity and protective efficacy against malaria challenge using combinations of plasmid DNA, recombinant modified vaccinia virus Ankara, fowlpox virus, and non-replicating adenovirus. We have proceeded to test immunogenicity and efficacy of successful heterologous prime-boost vaccines in phase I/IIa trials in malaria naïve subjects in the UK and in semi-immune individuals in The Gambia. …”
    Journal article
  19. 39

    Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic... by Bejon, P, Mwacharo, J, Kai, O, Todryk, S, Keating, S, Lang, T, Gilbert, S, Peshu, N, Marsh, K, Hill, A

    Published 2006
    “…The regimes used two recombinant viral vectors, attenuated fowlpox strain FP9 and modified vaccinia virus Ankara (MVA). …”
    Journal article
  20. 40

    Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area. by Bejon, P, Kai, O, Mwacharo, J, Keating, S, Lang, T, Gilbert, S, Peshu, N, Marsh, K, Hill, A

    Published 2006
    “…The component vaccinations were recombinant attenuated viruses, either fowlpox (FP) 9 or modified vaccinia virus Ankara (MVA). …”
    Journal article